1. Home
  2. LBRDA vs RGC Comparison

LBRDA vs RGC Comparison

Compare LBRDA & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Broadband Corporation

LBRDA

Liberty Broadband Corporation

HOLD

Current Price

$48.36

Market Cap

8.3B

ML Signal

HOLD

Logo Regencell Bioscience Holdings Limited

RGC

Regencell Bioscience Holdings Limited

HOLD

Current Price

$16.95

Market Cap

8.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBRDA
RGC
Founded
2014
2014
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
8.4B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LBRDA
RGC
Price
$48.36
$16.95
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$115.00
N/A
AVG Volume (30 Days)
143.9K
210.3K
Earning Date
11-05-2025
10-24-2025
Dividend Yield
N/A
N/A
EPS Growth
1.38
N/A
EPS
5.51
N/A
Revenue
$1,016,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$37.46
N/A
P/E Ratio
$8.73
N/A
Revenue Growth
306.40
N/A
52 Week Low
$44.51
$0.09
52 Week High
$102.38
$83.60

Technical Indicators

Market Signals
Indicator
LBRDA
RGC
Relative Strength Index (RSI) 49.16 61.44
Support Level $44.72 $16.10
Resistance Level $49.84 $18.10
Average True Range (ATR) 1.30 1.59
MACD 0.69 0.56
Stochastic Oscillator 70.70 83.25

Price Performance

Historical Comparison
LBRDA
RGC

About LBRDA Liberty Broadband Corporation

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: